Because of its versatility the Economist described the drug behaved 'like a molecular Swiss Army knife' (Economist)
The medication's pharmacokinetic profile includes a half-life of approximately five days, allowing for steady-state concentrations and consistent therapeutic effects throughout the week
June 3, 2025: Courts May Have to Decide on Diagnosis Criteria in Rybelsus Lawsuits Many patients harmed by Rybelsus have joined a group lawsuit for people harmed by GLP-1 drugs
Donts: Following few donts are advised: Stop smoking before 2, 3 weeks before treatment
Understanding the link between depression and weight Depression and obesity each increase the risk of the other, through both physical and emotional pathways
Many doctors prescribe Mounjaro off-label for people with: A BMI of 30 or higher (classified as obesity), or A BMI of 27 or higher, along with other weight-related health issues like high blood pressure, high cholesterol, or sleep apnea